Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/184763
Manipulating TLR signaling increases the anti-tumor T Cell response induced by viral cancer therapies
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
The immune response plays a key role in enhancing the therapeutic activity of oncolytic virotherapies. However, to date, investigators have relied on inherent interactions between the virus and the immune system, often coupled to the expression of a single cytokine transgene. Recently, the importance of TLR activation in mediating adaptive immunity has been demonstrated. We therefore sought to influence the type and level of immune response raised after oncolytic vaccinia therapy through manipulation of TLR signaling. Vaccinia naturally activates TLR2, associated with an antibody response, whereas a CTL response is associated with TLR3-TRIF-signaling pathways. We manipulated TLR signaling by vaccinia through deglycosylation of the viral particle to block TLR2 activation and expression of a TRIF transgene. The resulting vector displayed greatly reduced production of anti-viral neutralizing antibody as well as an increased anti-tumor CTL response. Delivery in both naive and pre-treated mice was enhanced and immunotherapeutic activity dramatically improved.
Matèries
Matèries (anglès)
Citació
Citació
ROJAS, Juan josé, SAMPATH, Padma, BONILLA, Braulio, ASHLEY, Alexandra, HOU, Weizhou, BYRD, Daniel, THORNE, Steve h.. Manipulating TLR signaling increases the anti-tumor T Cell response induced by viral cancer therapies. _Cell Reports_. 2016. Vol. 15, núm. 264-273. [consulta: 23 de gener de 2026]. ISSN: 2211-1247. [Disponible a: https://hdl.handle.net/2445/184763]